HYBRID EVENT: You can participate in person at Madrid, Spain or Virtually from your home or work.
5th Edition of Cardiology World Conference
September 5-7, 2024 | Madrid, Spain
Womens Cardiovascular Health: Cardiac Problems during Pregnancy
Womens Cardiovascular Health: Cardiac Problems during Pregnancy
Cardiac Problems during Pregnancy: Cardiac problems during pregnancies include symptoms like fatigue, chest pain, and shortness of breath, fainting, difficulty breathing while sleeping. Fainting occurs due to blood pressure and volume changes in pregnancy.
Common heart problems that affect women include:
- Shunt lesions
- Obstructive Lesions
- Complex lesions
- Cyanotic heart disease
Committee Members
Robert J Chilton
UT Health San Antonio, United States
Naranjan Dhalla
St. Boniface Hospital Albrechtsen Research Centre, Canada
Yong Xiao Wang
Albany Medical Center, United States Cardio 2024 Speakers
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Jose Maria Castellano Vazquez
National Center for Cardiovascular Research (CNIC), Spain
Maria Borrell
Institut de Recerca Sant Pau - Centre CERCA, Spain
Osama ElmaraghI
MOH Kuwait, KuwaitSubmit your abstract Today
Title : Antiplatelet agents as a novel therapy of heart failure due to myocardial infarction
Naranjan Dhalla, St. Boniface Hospital Albrechtsen Research Centre, Canada
Title : Advanced molecular and cellular mechanisms for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : Protecting cardiac potassium channels as a novel strategy to prevent ischemia-associated arrhythmias and sudden cardiac death
Shetuan Zhang, Queen’s University, Canada
Title : System methods to define master regulator of cell identity in development and diseases
Kaifu Chen, Cardiology Department, Boston Children’s Hospital, Boston, MA, USA, United States
Title : Left atrial appendage occlusion during cardiac surgery to prevent stroke: A systematic review and meta-analysis
Alaa A Sayed, UPMC, United States
Title : Optimal adoption of the CNIC-polypill strategy (acetyl salicylic acid, atorvastatin and ramipril) in routine clinical practice: Global expert consensus and endorsement for enhanced cardiovascular outcomes
Jose Maria Castellano Vazquez, National Center for Cardiovascular Research (CNIC), Spain